ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.21
-0.11%
US Tech 100
20,606.40
-0.03%
다우존스 지수
44,704.17
-0.17%
Bitcoin
95,154.57
-0.74%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Theraclion (ALTHE) 시세

Theraclion

Theraclion (ALTHE)

EU
0.362
0.008
(2.26%)
마감 04 12월 1:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
0.362
매수가
0.36
매도가
0.363
거래량
1,507
0.355 일간 변동폭 0.362
0.286 52주 범위 0.68
market_cap
16.555M
전일 종가
0.354
개장가
0.355
최근 거래 시간
655
@
0.362
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
14,979
발행 주식
45,732,250
배당수익률
-
주가수익률
-4.48
주당순이익(EPS)
-0.08
매출
3.92M
순이익
-3.68M

Theraclion 정보

섹터
Med, Dental, Hosp Eq-whsl
산업
Med, Dental, Hosp Eq-whsl
웹사이트
www.theraclion.com
본부
Malakoff, Hauts-de-seine, Fra
설립됨
-
Theraclion is listed in the Med, Dental, Hosp Eq-whsl sector of the 유로넥스트 (Euronext) with ticker ALTHE. The last closing price for Theraclion was 0.35 €. Over the last year, Theraclion shares have traded in a share price range of 0.286 € to 0.68 €.

Theraclion currently has 45,732,250 shares in issue. The market capitalisation of Theraclion is 16.19 € million. Theraclion has a price to earnings ratio (PE ratio) of -4.48.

ALTHE 최신 뉴스

추가 뉴스

THERACLION MARQUE DES AVANCÉES MAJEURES ET ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE

Fort de ses avancées sur ses priorités de 2023 et 2024 - accès au marché américain, R&D et Chine - Theraclion planifie sa montée en puissance commerciale sur 2025 et 2026. Étude pivotale pour...

31 10월 2024
Business Wire

THERACLION CONFIRME SES RÉALISATIONS DU PREMIER SEMESTRE

Priorités : Accès au marché américain, R&D et Chine. Principales réalisations du premier semestre 2024 : Étude pivot de la FDA : traitements terminés en juin, comme prévu ; Progrès...

07 9월 2024
Business Wire

SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy...

25 6월 2024
Business Wire

Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces that...

07 6월 2024
Business Wire

THERACLION MET À DISPOSITION SON RAPPORT FINANCIER 2023

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour la thérapie non invasive par ultrasons focalisés de haute intensité...

26 4월 2024
Business Wire

Theraclion Announces 2023 Financial Results and Continues Its Roadmap

Continuation of the strategy focused on access to the US and Chinese markets for SONOVEIN®, and its improvement through R&D; Rapid start-up of the pivotal study in the United States:...

28 3월 2024
Business Wire
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.0216.158357771260.3410.3710.325116110.34199102DE
4-0.008-2.162162162160.370.3850.312113710.3528308DE
120.0051.400560224090.3570.450.311149790.38026123DE
26-0.012-3.208556149730.3740.450.286286210.34741405DE
520.0226.470588235290.340.680.286300840.38258815DE
156-0.988-73.18518518521.351.6250.286205900.67779737DE
260-1.298-78.19277108431.662.760.286206741.10383472DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

토론

전체 피드 보기
NickyCapone NickyCapone 5 분 전
https://share.icloud.com/photos/0bbZF_t9tlGxTHW381mAjW_Ow
AMC
PonkenPlonken PonkenPlonken 5 분 전
Thank you for sharing!
They seem to believe this makes it to market in CRC is my read.
NVCR
coolhandluke88 coolhandluke88 6 분 전
If you voted for Kamala enough said. You better just get out of the markets and not prosper this next 4 years. Hilter are you seriously peddling that bs. Such week minds.
GRST
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 분 전
Must be the peeps waiting on the 20 year audit, or the best chart in the OTC, or HUGE news coming?

Has to be one of those, no?
SPZI
Serpico2005 Serpico2005 6 분 전
I'm asking the same questions, it seems people are losing patience with this. 
SPZI
flipper44 flipper44 6 분 전
Market Makers are writing their own damages epitaph.
NWBO
Jetmek_03052 Jetmek_03052 6 분 전
It would be just like Linda to file the application for the QB level, while knowing that the company's governance situation made them ineligible for it.

That way, she could put out a nice fluffy update, claiming that DBMM was "working" with the OTCM to uplist to the QB level. She wou
DBMM OTCM
Gmenfan Gmenfan 6 분 전
The Governors and Mayors that want to hinder ICE may want to take a different stance!
Rodney5 Rodney5 6 분 전
FFFacts, as you said be concise and clear. There is not an unlimited amount of funding available from the Treasury.

The difference in what the Treasury had authority to do and what actually happened during conservatorship as it relates to Treasury's actions, simplified.
FNMA
pzottkpz pzottkpz 7 분 전
⏲️

💲TLRY
TLRY
AJH92 AJH92 7 분 전
Update - December 3: "Check out the article from Fox News Digital. They reached out to our CEO, Tony Torgerud a couple weeks ago with some questions.

https://foxnews.com/food-drink/beer-taste-great-there-health-benefits-associated

#doinitright #themissingelemwntyounee
APRU
delerious1 delerious1 7 분 전
CHARBONE HYDROGEN CORPORATION ("CH")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: October 2, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 1,800,000 common shares at a deemed price of $0.10 per comm
Werbe Werbe 7 분 전
Mexedia owns Phonetime and Matchcom, theyre obligors on the 44 million loan. They are paying a million a month to pay this off. If they default, credit facility takes all Mexedia assets.

A default under our $45 million credit facility agreement could result in our lender foreclosing
RDAR
delerious1 delerious1 7 분 전
CHARBONE HYDROGEN CORPORATION ("CH")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: October 2, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 1,800,000 common shares at a deemed price of $0.10 per comm
CHHYF
solidgold solidgold 7 분 전
MANIPULATION.
NBRI
Gmenfan Gmenfan 8 분 전
I wonder what the Governors and Mayors that are going to hinder ICE think about the ruling?
georgie18 georgie18 9 분 전
Thanks Pink...🥳
oldstocks oldstocks 9 분 전
Because i told everyone on all the boards to boycott the stock until the company posts more often and more details.

That means, no selling, no buying

That also means for the company not to issue any new shares because we are not buying until they inform us on LinkedIn
AFFU
FooBarAndGrill FooBarAndGrill 9 분 전
Loaded at $38!!! Oh really?
https://investorshub.advfn.com/uimage/uploads/2024/12/3/ilnlxScreenshot_2024-12-03_11.17.17_AM.png
SMCI
jimmybob jimmybob 9 분 전
PTON back over 10
PTON
coolhandluke88 coolhandluke88 9 분 전
Keep drinking the Kool aid you idiot. Jim Jones needed idiots like you. Biden wasn't going to pardon Hunter too. lol
GRST

최근 히스토리

EU
ALTHE
Theraclion
LSE
CLON
Clontarf Energy
EU
ALSMA
SMAIO
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TSX
MFI
Maple Leaf Foods
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유